Axsome Therapeutics, Inc.

    Jurisdiction
    United States
    LEI
    549300EXGR0XLRJEIB95
    ISIN
    US05464T1043 (AXSM)
    Sectors
    1. Healthcare
    2. Biotechnology

    Scores

    InsiderPie Expert Score
    trending_flat 45 / 100
    Worse than peer group:
    50 / 100
    Fair value (Benjamin Graham formula)
    N/A
    Financial strength (Piotroski F-Value)
    5 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    2 / 7

    Profile

    Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. Read full profile

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Fundamentals

    Net revenue
    €424.74M
    Gross margin
    91.5%
    EBIT
    -€196.43M
    EBIT margin
    -46.2%
    Net income
    -€211.84M
    Net margin
    -49.9%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    €826.98M +94.7% €25.28M -111.9%
    €1.26B +51.8% €320.30M +1,167.1%
    €1.73B +37.8% €643.91M +101.0%

    Dividends

    No dividend payouts

    Insider Transactions

    Name Title Transaction Date Shares Price Value
    Saad Mark E N/A -9.1K $125.07 -$1.14M
    JEFFS ROGER N/A -13K $123.68 -$1.67M
    JEFFS ROGER N/A -60K $121.72 -$7.30M
    JEFFS ROGER N/A -37K $120.05 -$4.41M

    Earnings Calls

    Latest earnings call: May 6, 2024

    Investor transactions

    Name Shares Value Last change Change type
    Peter Brown 134K $15.68M +68K Buy

    Add to watchlist

    Notifications